ANA380: Interim Phase II data

Interim data from an open-label, dose-escalation, Chinese and Korean Phase II trial in

Read the full 133 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE